Related Experiment Video

Updated: Mar 7, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.5K

miR-181a Inhibits Cervical Cancer Development via Downregulating GRP78

Chengyan Luo, Jiangnan Qiu

    Oncology Research
    |March 1, 2017
    PubMed

    Insights

    MicroRNA-181a (miR-181a) suppresses cervical cancer growth and oxaliplatin resistance by targeting HSPA5/GRP78. Low miR-181a and high GRP78 expression correlate with poor survival, indicating GRP78 as a potential therapeutic target.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Cervical cancer remains a significant global health issue for women.
    • MicroRNAs (miRs) play crucial roles in cancer development and progression.
    • Understanding miR-181a's function is vital for novel cervical cancer therapies.

    Purpose of the Study:

    • To investigate the role of miR-181a in cervical cancer development.
    • To identify miR-181a's molecular target and its function in cervical cancer.
    • To explore the link between miR-181a, its target, and chemotherapy resistance.

    Main Methods:

    • Expression analysis of miR-181a in human cervical cancer cell lines.
    • In vitro and in vivo studies (mouse xenografts) to assess miR-181a's function.
    • Identification and validation of HSPA5/GRP78 as miR-181a's target.

    Main Results:

    • Distinct miR-181a expression profile observed in cervical cancer cell lines.
    • Low miR-181a expression correlated with increased cervical cancer growth and oxaliplatin resistance.
    • HSPA5/GRP78 identified as a direct target; its upregulation promoted proliferation and resistance.
    • High GRP78 expression linked to poor survival in a cervical cancer patient cohort.

    Conclusions:

    • miR-181a inhibits cervical cancer progression by downregulating GRP78.
    • GRP78 acts as an oncogenic factor in cervical cancer, promoting tumor growth and chemoresistance.
    • GRP78 represents a promising therapeutic target for cervical cancer treatment.

    More Related Videos

    Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

    Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

    Published on: April 7, 2017

    9.9K
    In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

    In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

    Published on: August 23, 2019

    7.8K

    Related Concept Videos

    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
    4.2K
    MicroRNAs01:22

    MicroRNAs

    MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
    24.4K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    5.3K
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    8.2K
    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
    4.9K
    Receptor Downregulation in MVBs01:15

    Receptor Downregulation in MVBs

    Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
    The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
    2.9K